Life science software market seen reaching $34.45 billion by 2030

By AI, Created 1:12 PM UTC, June 04, 2026, /AGP/ – The Business Research Company says the life science software market will grow from $20.07 billion in 2025 to $22.29 billion in 2026, with North America leading and Asia-Pacific set to grow fastest. The report points to rising clinical trial complexity, digital record-keeping and regulatory pressure as key reasons the sector is expanding.

Why it matters: - Life science software is becoming core infrastructure for drug discovery, clinical trials, pharmacovigilance and regulatory compliance. - The market’s projected growth signals continued demand for tools that can handle complex data, improve efficiency and support scale across life sciences. - A larger software stack can also help life science teams standardize records and improve interoperability across research and compliance workflows.

What happened: - The Business Research Company released a 2026 life science software market report on June 4, 2026. - The report says the market will rise from $20.07 billion in 2025 to $22.29 billion in 2026. - The report projects the market will reach $34.45 billion by 2030. - The report covers market dynamics, segment insights, regional outlook, company strategies and emerging trends.

The details: - The 2026 growth forecast implies a 11.1% compound annual growth rate. - The 2030 outlook implies an 11.5% compound annual growth rate from 2026. - Growth in 2025-2026 is tied to more life science research, more complex clinical trials, wider use of digital record-keeping and continued expansion in pharmaceuticals and biotechnology. - The longer-term forecast is driven by demand for scalable software platforms, pressure to improve operational efficiency and a rising number of clinical trials worldwide. - The report also cites broader use of software in pharmacovigilance and more investment in digital infrastructure for life sciences. - The main trends highlighted are integrated life science platforms, workflow automation, regulatory compliance software, and broader use in clinical and preclinical settings. - The report defines life science software as specialized applications and platforms that support workflows across the life sciences sector. - The report says these tools support research capabilities, process management and productivity across drug discovery, clinical trials and compliance. - North America was the largest market in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period. - Other regions covered include South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The 2026 report adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technology analysis, future trend analysis and updated graphics and tables. - The company is offering a free sample report and the full market report.

Between the lines: - The report points to a market shifting from basic digitization toward more integrated, automated and compliance-focused software stacks. - The emphasis on interoperability and data standardization suggests buyers want systems that connect research, operations and regulatory needs rather than isolated tools. - The regional split suggests mature adoption in North America and faster catch-up growth in Asia-Pacific.

What’s next: - The market is expected to keep expanding through 2030 as life sciences companies invest in software that can support scale, compliance and faster workflows. - The report’s added analytics features suggest vendors and investors are focusing more on benchmarking, forecasting and market mapping. - Related reports on life science analytics and artificial intelligence in life sciences are also available from The Business Research Company.